Modeling Study Published in Clinical Gastroenterology and Hepatology Validates Geneoscopy’s ColoSense® Real-World Screening Impact
ST. LOUIS, Mo.—June 24, 2025 — Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
Geneoscopy’s RNA-based ColoSense® Test Included in Latest National Comprehensive Cancer Network® (NCCN) Guidelines
ColoSense recommended as a first-line test for colorectal cancer screening, with a three-year screening interval ST. LOUIS, Mo.—June 3, 2025 —…
Geneoscopy Sibling Co-founders Named Finalists for EY Entrepreneur Of The Year® 2025 Heartland Award
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future
Geneoscopy’s Dr. Erica Barnell to Speak at ACG’s ‘Leading With Guts’ Course on Expanding Career Opportunities in Gastroenterology
ST. LOUIS, Mo. – March 4, 2025 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy’s Petition Challenging Validity of a Second Patent Owned by Exact Sciences
ST. LOUIS, Mo. – February 18, 2025 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests
Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for…
Geneoscopy’s Dr. Erica Barnell to Present at Women @ Work Summit and American Gastroenterological Association (AGA) Workshop
Presentations to inspire the next generation of woman scientists and highlight recent advancements in colorectal cancer screening ST. LOUIS, Mo. –…
Geneoscopy Receives New York State Department of Health Permit, Expanding Ability to Provide Laboratory Services Nationwide
ST. LOUIS, Mo. – October 1, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…